Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Magenta Therapeutics, Inc.

Magenta Therapeutics Reports Third Quarter Financial Results and Program Highlights
From Magenta Therapeutics, Inc.
Via Business Wire
Tickers MGTA
Magenta Therapeutics Appoints Jeffrey Humphrey, M.D. as Chief Medical Officer
From Magenta Therapeutics, Inc.
Via Business Wire
Tickers MGTA
Magenta Therapeutics to Participate in 2021 Cantor Virtual Global Healthcare Conference
From Magenta Therapeutics, Inc.
Via Business Wire
Tickers MGTA
Magenta Therapeutics Announces IND Clearance for MGTA-117 Targeted Conditioning Clinical Trial
From Magenta Therapeutics, Inc.
Via Business Wire
Tickers MGTA
Magenta Therapeutics Reports Second Quarter Financial Results and Recent Program Highlights
From Magenta Therapeutics, Inc.
Via Business Wire
Tickers MGTA
Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in August
From Magenta Therapeutics, Inc.
Via Business Wire
Tickers MGTA
Magenta Therapeutics Announces Update on U.S. FDA Investigational New Drug Application for MGTA-117 in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
From Magenta Therapeutics, Inc.
Via Business Wire
Tickers MGTA
Magenta Therapeutics Appoints Caren Deardorf as Chief Commercial Officer
From Magenta Therapeutics, Inc.
Via Business Wire
Tickers MGTA
Magenta Therapeutics Announces $86.4 Million Common Stock Investment from Multiple Investors
From Magenta Therapeutics, Inc.
Via Business Wire
Tickers MGTA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.